市場調査レポート

商品コード

1422772

免疫診断の世界市場：製品タイプ別、用途別、エンドユーザー別、地域別、機会、予測、2017年～2031年

Immunodiagnostics Market Assessment, By Type, By Product, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日: 2024年02月12日
発行: Market Xcel - Markets and Data
ページ情報: 英文 238 Pages
納期: 3～5営業日

カスタマイズ可能

価格

PDF & Excel Printable (Single User License)

USD 4,500 648,270円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 5,700 821,142円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,200 1,181,292円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の免疫診断の市場規模は、2023年に212億1,000万米ドルと評価され、2031年には458億米ドルに達すると予測されており、2024年から2031年の予測期間のCAGRは10.1%になるとみられています。世界の免疫診断市場を牽引する要因には、感染症の急増、診断技術の進歩、個別化医療に対する需要の高まり、病気の早期発見に対する意識の高まりなどが挙げられます。さらに、高齢化、ヘルスケアインフラの改善、自己免疫疾患の増加といった要因も、免疫診断市場の成長に拍車をかけています。

世界の免疫診断市場は、様々な相互関連要因によって上昇基調にあります。重要な促進要因のひとつは、世界の感染症の流行です。この急増により効率的な診断ツールが必要となり、先進的な免疫診断技術の開発と導入が進んでいます。このような技術の進歩は、より正確で迅速な疾患の特定を容易にし、世界の免疫診断市場の成長に極めて重要な役割を果たしています。もう一つの要因は、個別化医療に対する需要の高まりです。免疫反応に個人差があることが認識され、オーダーメイドの診断アプローチに対するニーズが急増しています。免疫系の機能を評価し、特定のバイオマーカーを同定する能力を持つ免疫診断は、個別化医療の要求に完全に合致しています。

さらに、疾病の早期発見に関する意識の高まりは、世界のヘルスケアシステムにおいて重要な焦点となっています。免疫診断は、様々な疾患の早期発見を可能にし、タイムリーな介入と患者の予後改善をもたらします。さらに、高齢化などの人口動態の変化が免疫診断ソリューションの需要を押し上げています。年齢が上がるにつれて、様々な疾患への感受性が高まり、精密な診断ツールへの要求が高まっています。さらに、自己免疫疾患の増加は、これらの複雑な疾患を管理する上で正確な診断とモニタリングが不可欠となるため、世界の免疫診断市場の成長をさらに促進しています。

個別化医療へのニーズの高まりが、世界の免疫診断市場の成長を刺激しています。特定の個人の特徴に合わせた治療を行うことで、悪影響を抑えながら効果を最大化することができます。免疫診断は、病気に対する身体の免疫反応を評価することで、正確な治療法の選択と診断に役立つという重要な役割を果たしています。需要の急増は様々な要因から生じています。ゲノミクスやプロテオミクスのような技術の進歩は、個々の患者の特徴をより深く理解することを可能にし、標的治療を容易にします。また、慢性疾患や感染症の流行は、正確で迅速な診断の必要性を浮き彫りにしており、免疫診断の能力と完全に合致しています。

さらに、世界人口の高齢化に伴い、よりオーダーメイドのヘルスケアソリューションが求められており、市場の拡大をさらに後押ししています。継続的な動向が免疫診断分野の成長を促進すると予想されます。技術革新と投資は、より洗練され、正確で、個別化された診断ツールの創造につながり、ヘルスケア提供システムを大きく変革します。

当レポートでは、世界の免疫診断市場について調査し、市場の概要とともに、製品タイプ別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1. Global Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 2. Global Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
Figure 3. Global Immunodiagnostics Market Share (%), By Type, 2017-2031F
Figure 4. Global Immunodiagnostics Market Share (%), By Product, 2017-2031F
Figure 5. Global Immunodiagnostics Market Share (%), By Application, 2017-2031F
Figure 6. Global Immunodiagnostics Market Share (%), By End-user, 2017-2031F
Figure 7. Global Immunodiagnostics Market Share (%), By Region, 2017-2031F
Figure 8. North America Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 9. North America Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
Figure 10. North America Immunodiagnostics Market Share (%), By Type, 2017-2031F
Figure 11. North America Immunodiagnostics Market Share (%), By Product, 2017-2031F
Figure 12. North America Immunodiagnostics Market Share (%), By Application, 2017-2031F
Figure 13. North America Immunodiagnostics Market Share (%), By End-user, 2017-2031F
Figure 14. North America Immunodiagnostics Market Share (%), By Country, 2017-2031F
Figure 15. United States Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 16. United States Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
Figure 17. United States Immunodiagnostics Market Share (%), By Type, 2017-2031F
Figure 18. United States Immunodiagnostics Market Share (%), By Product, 2017-2031F
Figure 19. United States Immunodiagnostics Market Share (%), By Application, 2017-2031F
Figure 20. United States Immunodiagnostics Market Share (%), By End-user, 2017-2031F
Figure 21. Canada Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 22. Canada Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
Figure 23. Canada Immunodiagnostics Market Share (%), By Type, 2017-2031F
Figure 24. Canada Immunodiagnostics Market Share (%), By Product, 2017-2031F
Figure 25. Canada Immunodiagnostics Market Share (%), By Application, 2017-2031F
Figure 26. Canada Immunodiagnostics Market Share (%), By End-user, 2017-2031F
Figure 27. Mexico Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 28. Mexico Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
Figure 29. Mexico Immunodiagnostics Market Share (%), By Type, 2017-2031F
Figure 30. Mexico Immunodiagnostics Market Share (%), By Product, 2017-2031F
Figure 31. Mexico Immunodiagnostics Market Share (%), By Application, 2017-2031F
Figure 32. Mexico Immunodiagnostics Market Share (%), By End-user, 2017-2031F
Figure 33. Europe Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 34. Europe Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
Figure 35. Europe Immunodiagnostics Market Share (%), By Type, 2017-2031F
Figure 36. Europe Immunodiagnostics Market Share (%), By Product, 2017-2031F
Figure 37. Europe Immunodiagnostics Market Share (%), By Application, 2017-2031F
Figure 38. Europe Immunodiagnostics Market Share (%), By End-user, 2017-2031F
Figure 39. Europe Immunodiagnostics Market Share (%), By Country, 2017-2031F
Figure 40. Germany Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 41. Germany Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
Figure 42. Germany Immunodiagnostics Market Share (%), By Type, 2017-2031F
Figure 43. Germany Immunodiagnostics Market Share (%), By Product, 2017-2031F
Figure 44. Germany Immunodiagnostics Market Share (%), By Application, 2017-2031F
Figure 45. Germany Immunodiagnostics Market Share (%), By End-user, 2017-2031F
Figure 46. France Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 47. France Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
Figure 48. France Immunodiagnostics Market Share (%), By Type, 2017-2031F
Figure 49. France Immunodiagnostics Market Share (%), By Product, 2017-2031F
Figure 50. France Immunodiagnostics Market Share (%), By Application, 2017-2031F
Figure 51. France Immunodiagnostics Market Share (%), By End-user, 2017-2031F
Figure 52. Italy Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 53. Italy Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
Figure 54. Italy Immunodiagnostics Market Share (%), By Type, 2017-2031F
Figure 55. Italy Immunodiagnostics Market Share (%), By Product, 2017-2031F
Figure 56. Italy Immunodiagnostics Market Share (%), By Application, 2017-2031F
Figure 57. Italy Immunodiagnostics Market Share (%), By End-user, 2017-2031F
Figure 58. United Kingdom Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 59. United Kingdom Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
Figure 60. United Kingdom Immunodiagnostics Market Share (%), By Type, 2017-2031F
Figure 61. United Kingdom Immunodiagnostics Market Share (%), By Product, 2017-2031F
Figure 62. United Kingdom Immunodiagnostics Market Share (%), By Application, 2017-2031F
Figure 63. United Kingdom Immunodiagnostics Market Share (%), By End-user, 2017-2031F
Figure 64. Russia Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 65. Russia Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
Figure 66. Russia Immunodiagnostics Market Share (%), By Type, 2017-2031F
Figure 67. Russia Immunodiagnostics Market Share (%), By Product, 2017-2031F
Figure 68. Russia Immunodiagnostics Market Share (%), By Application, 2017-2031F
Figure 69. Russia Immunodiagnostics Market Share (%), By End-user, 2017-2031F
Figure 70. Netherlands Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 71. Netherlands Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
Figure 72. Netherlands Immunodiagnostics Market Share (%), By Type, 2017-2031F
Figure 73. Netherlands Immunodiagnostics Market Share (%), By Product, 2017-2031F
Figure 74. Netherlands Immunodiagnostics Market Share (%), By Application, 2017-2031F
Figure 75. Netherlands Immunodiagnostics Market Share (%), By End-user, 2017-2031F
Figure 76. Spain Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 77. Spain Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
Figure 78. Spain Immunodiagnostics Market Share (%), By Type, 2017-2031F
Figure 79. Spain Immunodiagnostics Market Share (%), By Product, 2017-2031F
Figure 80. Spain Immunodiagnostics Market Share (%), By Application, 2017-2031F
Figure 81. Spain Immunodiagnostics Market Share (%), By End-user, 2017-2031F
Figure 82. Turkey Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 83. Turkey Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
Figure 84. Turkey Immunodiagnostics Market Share (%), By Type, 2017-2031F
Figure 85. Turkey Immunodiagnostics Market Share (%), By Product, 2017-2031F
Figure 86. Turkey Immunodiagnostics Market Share (%), By Application, 2017-2031F
Figure 87. Turkey Immunodiagnostics Market Share (%), By End-user, 2017-2031F
Figure 88. Poland Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 89. Poland Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
Figure 90. Poland Immunodiagnostics Market Share (%), By Type, 2017-2031F
Figure 91. Poland Immunodiagnostics Market Share (%), By Product, 2017-2031F
Figure 92. Poland Immunodiagnostics Market Share (%), By Application, 2017-2031F
Figure 93. Poland Immunodiagnostics Market Share (%), By End-user, 2017-2031F
Figure 94. South America Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 95. South America Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
Figure 96. South America Immunodiagnostics Market Share (%), By Type, 2017-2031F
Figure 97. South America Immunodiagnostics Market Share (%), By Product, 2017-2031F
Figure 98. South America Immunodiagnostics Market Share (%), By Application, 2017-2031F
Figure 99. South America Immunodiagnostics Market Share (%), By End-user, 2017-2031F
Figure 100. South America Immunodiagnostics Market Share (%), By Country, 2017-2031F
Figure 101. Brazil Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 102. Brazil Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
Figure 103. Brazil Immunodiagnostics Market Share (%), By Type, 2017-2031F
Figure 104. Brazil Immunodiagnostics Market Share (%), By Product, 2017-2031F
Figure 105. Brazil Immunodiagnostics Market Share (%), By Application, 2017-2031F
Figure 106. Brazil Immunodiagnostics Market Share (%), By End-user, 2017-2031F
Figure 107. Argentina Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 108. Argentina Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
Figure 109. Argentina Immunodiagnostics Market Share (%), By Type, 2017-2031F
Figure 110. Argentina Immunodiagnostics Market Share (%), By Product, 2017-2031F
Figure 111. Argentina Immunodiagnostics Market Share (%), By Application, 2017-2031F
Figure 112. Argentina Immunodiagnostics Market Share (%), By End-user, 2017-2031F
Figure 113. Asia-Pacific Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 114. Asia-Pacific Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
Figure 115. Asia-Pacific Immunodiagnostics Market Share (%), By Type, 2017-2031F
Figure 116. Asia-Pacific Immunodiagnostics Market Share (%), By Product, 2017-2031F
Figure 117. Asia-Pacific Immunodiagnostics Market Share (%), By Application, 2017-2031F
Figure 118. Asia-Pacific Immunodiagnostics Market Share (%), By End-user, 2017-2031F
Figure 119. Asia-Pacific Immunodiagnostics Market Share (%), By Country, 2017-2031F
Figure 120. India Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 121. India Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
Figure 122. India Immunodiagnostics Market Share (%), By Type, 2017-2031F
Figure 123. India Immunodiagnostics Market Share (%), By Product, 2017-2031F
Figure 124. India Immunodiagnostics Market Share (%), By Application, 2017-2031F
Figure 125. India Immunodiagnostics Market Share (%), By End-user, 2017-2031F
Figure 126. China Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 127. China Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
Figure 128. China Immunodiagnostics Market Share (%), By Type, 2017-2031F
Figure 129. China Immunodiagnostics Market Share (%), By Product, 2017-2031F
Figure 130. China Immunodiagnostics Market Share (%), By Application, 2017-2031F
Figure 131. China Immunodiagnostics Market Share (%), By End-user, 2017-2031F
Figure 132. Japan Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 133. Japan Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
Figure 134. Japan Immunodiagnostics Market Share (%), By Type, 2017-2031F
Figure 135. Japan Immunodiagnostics Market Share (%), By Product, 2017-2031F
Figure 136. Japan Immunodiagnostics Market Share (%), By Application, 2017-2031F
Figure 137. Japan Immunodiagnostics Market Share (%), By End-user, 2017-2031F
Figure 138. Australia Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 139. Australia Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
Figure 140. Australia Immunodiagnostics Market Share (%), By Type, 2017-2031F
Figure 141. Australia Immunodiagnostics Market Share (%), By Product, 2017-2031F
Figure 142. Australia Immunodiagnostics Market Share (%), By Application, 2017-2031F
Figure 143. Australia Immunodiagnostics Market Share (%), By End-user, 2017-2031F
Figure 144. Vietnam Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 145. Vietnam Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
Figure 146. Vietnam Immunodiagnostics Market Share (%), By Type, 2017-2031F
Figure 147. Vietnam Immunodiagnostics Market Share (%), By Product, 2017-2031F
Figure 148. Vietnam Immunodiagnostics Market Share (%), By Application, 2017-2031F
Figure 149. Vietnam Immunodiagnostics Market Share (%), By End-user, 2017-2031F
Figure 150. South Korea Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 151. South Korea Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
Figure 152. South Korea Immunodiagnostics Market Share (%), By Type, 2017-2031F
Figure 153. South Korea Immunodiagnostics Market Share (%), By Product, 2017-2031F
Figure 154. South Korea Immunodiagnostics Market Share (%), By Application, 2017-2031F
Figure 155. South Korea Immunodiagnostics Market Share (%), By End-user, 2017-2031F
Figure 156. Indonesia Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 157. Indonesia Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
Figure 158. Indonesia Immunodiagnostics Market Share (%), By Type, 2017-2031F
Figure 159. Indonesia Immunodiagnostics Market Share (%), By Product, 2017-2031F
Figure 160. Indonesia Immunodiagnostics Market Share (%), By Application, 2017-2031F
Figure 161. Indonesia Immunodiagnostics Market Share (%), By End-user, 2017-2031F
Figure 162. Philippines Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 163. Philippines Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
Figure 164. Philippines Immunodiagnostics Market Share (%), By Type, 2017-2031F
Figure 165. Philippines Immunodiagnostics Market Share (%), By Product, 2017-2031F
Figure 166. Philippines Immunodiagnostics Market Share (%), By Application, 2017-2031F
Figure 167. Philippines Immunodiagnostics Market Share (%), By End-user, 2017-2031F
Figure 168. Middle East & Africa Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 169. Middle East & Africa Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
Figure 170. Middle East & Africa Immunodiagnostics Market Share (%), By Type, 2017-2031F
Figure 171. Middle East & Africa Immunodiagnostics Market Share (%), By Product, 2017-2031F
Figure 172. Middle East & Africa Immunodiagnostics Market Share (%), By Application, 2017-2031F
Figure 173. Middle East & Africa Immunodiagnostics Market Share (%), By End-user, 2017-2031F
Figure 174. Middle East & Africa Immunodiagnostics Market Share (%), By Country, 2017-2031F
Figure 175. Saudi Arabia Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 176. Saudi Arabia Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
Figure 177. Saudi Arabia Immunodiagnostics Market Share (%), By Type, 2017-2031F
Figure 178. Saudi Arabia Immunodiagnostics Market Share (%), By Product, 2017-2031F
Figure 179. Saudi Arabia Immunodiagnostics Market Share (%), By Application, 2017-2031F
Figure 180. Saudi Arabia Immunodiagnostics Market Share (%), By End-user, 2017-2031F
Figure 181. UAE Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 182. UAE Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
Figure 183. UAE Immunodiagnostics Market Share (%), By Type, 2017-2031F
Figure 184. UAE Immunodiagnostics Market Share (%), By Product, 2017-2031F
Figure 185. UAE Immunodiagnostics Market Share (%), By Application, 2017-2031F
Figure 186. UAE Immunodiagnostics Market Share (%), By End-user, 2017-2031F
Figure 187. South Africa Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 188. South Africa Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
Figure 189. South Africa Immunodiagnostics Market Share (%), By Type, 2017-2031F
Figure 190. South Africa Immunodiagnostics Market Share (%), By Product, 2017-2031F
Figure 191. South Africa Immunodiagnostics Market Share (%), By Application, 2017-2031F
Figure 192. South Africa Immunodiagnostics Market Share (%), By End-user, 2017-2031F
Figure 193. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 194. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 195. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Product Code: MX10970

Global immunodiagnostics market size was valued at USD 21.21 billion in 2023, expected to reach USD 45.8 billion in 2031, with a CAGR of 10.1% for the forecast period between 2024 and 2031F. Factors propelling the global immunodiagnostics market encompass the upsurge in infectious diseases, advancements in diagnostic technologies, amplified demand for personalized medicine, and heightened awareness regarding early disease detection. Moreover, the growth of the global immunodiagnostics market is fueled by factors such as the aging population, improvement in healthcare infrastructure, and increasing autoimmune conditions.

The global immunodiagnostics market is witnessing an upward trajectory due to various interconnected factors. One of the significant drivers is the increasing prevalence of infectious diseases worldwide. The surge necessitates efficient diagnostic tools, leading to the development and adoption of advanced immunodiagnostic techniques. These technological advancements play a pivotal role in the growth of the global immunodiagnostics market, facilitating more accurate and rapid disease identification. Another contributing factor is the amplified demand for personalized medicine. The recognition of individual variations in immune responses has led to a burgeoning need for tailored diagnostic approaches. Immunodiagnostics, with its ability to assess immune system functions and identify specific biomarkers, aligns perfectly with the requirements of personalized medicine.

Furthermore, heightened awareness regarding early disease detection has become a key focus across healthcare systems globally. Immunodiagnostics offers the advantage of early identification of various conditions, enabling timely intervention and improved patient outcomes. Moreover, demographic shifts, such as aging populations, drive the demand for immunodiagnostic solutions. As age increases, the susceptibility to various diseases rises, elevating the requirement for precise diagnostic tools. Additionally, the escalation of autoimmune conditions further fuels the growth of global immunodiagnostics market, as accurate diagnosis and monitoring become crucial in managing these complex diseases.

Amplified Demand for Personalized Medicine

The increased desire for personalized medicine has stimulated the growth of global immunodiagnostics market. Tailoring treatments to specific individual traits maximize effectiveness while reducing negative impacts. Immunodiagnostics play a crucial role by evaluating the body's immune response to illnesses, aiding in precise treatment choices and diagnoses. The surge in demand arises from various factors. Technological advancements like genomics and proteomics enable a deeper comprehension of individual patient characteristics, facilitating targeted therapies. Also, the growing prevalence of chronic and infectious diseases highlights the necessity for precise and rapid diagnostics, aligning perfectly with the capabilities of immunodiagnostics.

Moreover, the aging global population demands more tailored healthcare solutions, further propelling the market expansion. Continued trends are anticipated to drive the growth of the immunodiagnostics sector. Innovations and investments will lead to the creation of more refined, precise, and personalized diagnostic tools, significantly transforming healthcare delivery systems.

Advancing Technologies

Technological progress stands as a key driving force for the global immunodiagnostics market. Advances in genomics, proteomics, and data analytics enable a deep comprehension of individual biological intricacies, leading to the creation of extremely accurate diagnostic tools. These breakthroughs enable healthcare providers to thoroughly examine immune responses, facilitating quick and precise disease identification. The fusion of these innovative technologies boosts the effectiveness of immunodiagnostics and propels the development of tailored therapies, transforming healthcare by allowing customized treatments for each patient and elevating the expansion of the global immunodiagnostics market.

For instance, to minimize testing gaps for individuals with pre-diabetes and diabetes, healthcare start-up Orange Biomed introduced their reusable, pocket-sized OBM fast A1c test in the United States in April 2023. The OBM fast A1c technology, billed as the world's first glycated hemoglobin analyzer, was in June during the 83rd Scientific Sessions of the American Diabetes Association, which took place in San Diego, California.

Government Initiatives

Governments globally are actively implementing diverse strategies to strengthen the global immunodiagnostics market. These strategies involve financing research and development, cultivating partnerships between academic and industrial sectors and establishing regulatory structures that promote innovation. Through infrastructure investment, grant provisions, and clinical trials, governments strive to expedite the advancement and acceptance of sophisticated immunodiagnostic technologies. These combined endeavors drive market expansion and aspire to improve public health by encouraging early disease identification, enabling customized therapies, and ultimately advancing healthcare outcomes worldwide. For example, the government of Uttar Pradesh dispatched a delegation to visit three government hospitals in Varanasi in October 2023 to evaluate the situation given the rising number of fever patients in the district. The team evaluated the situation considering the rising number of fever patients in the district and ordered Elisa test kits for chikungunya, leptospirosis, scrub typhus, and other illnesses be made available at the Pandit Deendayal Upadhyay District Hospital in Pandeypur and the SSPG Divisional Hospital in Kabir Chaura.

Rising Demand for ELISA

The rising need for ELISA (Enzyme-Linked Immunosorbent Assay) tests significantly propel the expansion of global immunodiagnostics market. ELISA, known for its high sensitivity and specificity, identifies various diseases by measuring antibodies, proteins, or hormones in samples. Its adaptability in diagnosing infectious diseases, autoimmune conditions, and cancers drives its demand. Factors like increased disease prevalence, technological advancements, improving ELISA's precision, and its cost-effectiveness contribute to its prominence. Healthcare experts rely on ELISA for swift and accurate disease identification, making its increasing utilization a substantial factor in shaping the growth and direction of the global immunodiagnostics market. For example, Neogen Corporation stated in November 2023 that it has launched its third assay in its Veratox VIP range of improved quantitative ELISA solutions, the novel Veratox VIP assay for detecting walnut. The new Veratox VIP for Walnut allergy test keeps the straightforward testing process of the Veratox product range while exhibiting strong performance across sample types.

For Diagnosis of Infectious Diseases

The increase in infectious diseases is driving the growth of the global immunodiagnostics market. The rise in contagious illnesses worldwide requires fast and precise diagnostic tools for quick identification and treatment. Immunodiagnostics holds a crucial position by evaluating the body's immune reactions, assisting in accurate disease detection. Emerging pathogens, antimicrobial resistance, and increased global travel contribute to the surge in infectious diseases. Therefore, the growing demand for efficient diagnostic solutions matches the capabilities of immunodiagnostics, leading to its market expansion to address the urgent requirement for swift and accurate disease identification and treatment worldwide. For example, in September 2023, a group of researchers under the direction of Professor Johnjoe McFadden created a brand-new molecular test known as "Electro-chemical LAMP" (eLAMP), which is quick, inexpensive, sensitive, and able to be used in a hospital lab, GP office, or at home. When coupled to a smartphone, eLAMP allows at-home polymerase chain reaction (PCR) testing with the sensitivity of lab-based PCR assays.

Future Market Scenario

Several compelling factors contribute to a promising future for the global immunodiagnostics market. Ongoing technological advancements continually improve diagnostic tools, refining their precision and adaptability. The progress enables healthcare providers to conduct thorough assessments of immune responses, resulting in more precise disease diagnoses. Furthermore, the increasing demand for personalized medicine propels immunodiagnostics' growth by customizing treatments based on individual immune profiles.

Moreover, heightened government initiatives, including funding for research and development and the establishment of favorable regulatory frameworks, further fortifies the market. The global upsurge in chronic and infectious diseases, combined with an aging population, intensifies the need for advanced diagnostic solutions, aligning seamlessly with the capabilities of immunodiagnostics. These combined elements foreshadow a promising path for the global immunodiagnostics market, ensuring ongoing innovation, enhanced precision, and a significant transformative influence on global healthcare delivery.

Key Players Landscape and Outlook

Several prominent corporations are engaged in mergers and acquisitions in the global immunodiagnostics market. These strategic actions target resource consolidation, portfolio expansion, and acquiring innovative technologies. These efforts aid in creating extensive diagnostic solutions and fortifying market standings. Through acquisitions or mergers, firms can combine strengths, expertise, and optimize operations, improving competitiveness. The calculated approach consolidates the market and propels innovations in immunodiagnostic technologies, potentially transforming the industry landscape and enhancing healthcare outcomes more broadly. As an example, in May 2023, the privately held biotech business Freenome announced that it had purchased Oncimmune Ltd., a UK-based global immunodiagnostics developer with a commercialized CE-IVD marked EarlyCDT Lung blood test, an autoantibody platform, and a research and development pipeline of more than seven major cancer detection signatures. By adding more indicators crucial for cancer detection to its autoantibody technology, the acquisition expands Freenome's product offering.

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Immunodiagnostics Market Outlook, 2017-2031F

4.1. Market Size & Forecast
- 4.1.1. Value
- 4.1.2. Volume
4.2. By Type
- 4.2.1. Radioimmunoassay (RIA)
- 4.2.2. ELISA
- 4.2.3. Chemiluminescent immunoassay (CLIA)
- 4.2.4. Fluorescent immunoassay (FIA)
- 4.2.5. Lateral flow assay (LFA)
- 4.2.6. Rapid Test
- 4.2.7. Others
4.3. By Product
- 4.3.1. Reagents
- 4.3.2. Instruments
- 4.3.3. Software & Services
4.4. By Application
- 4.4.1. Oncology
- 4.4.2. Endocrinology
- 4.4.3. Infectious diseases, Allergy & Autoimmune Diseases
- 4.4.4. Environmental Pollution
- 4.4.5. Food Technology
- 4.4.6. Proteomics
- 4.4.7. Cardiac Biomarker
- 4.4.8. Drug Monitoring
- 4.4.9. Others
4.5. By End-user
- 4.5.1. Hospitals
- 4.5.2. Clinical Laboratories
- 4.5.3. Academics & Research Centers
- 4.5.4. Pharma & Biotech Industry
- 4.5.5. Others
4.6. By Region
- 4.6.1. North America
- 4.6.2. Europe
- 4.6.3. South America
- 4.6.4. Asia-Pacific
- 4.6.5. Middle East and Africa
4.7. By Company Market Share (%), 2023

5. Global Immunodiagnostics Market Outlook, By Region, 2017-2031F

5.1. North America*
- 5.1.1. Market Size & Forecast
  - 5.1.1.1. Value
  - 5.1.1.2. Volume
- 5.1.2. By Type
  - 5.1.2.1. Radioimmunoassay (RIA)
  - 5.1.2.2. ELISA
  - 5.1.2.3. Chemiluminescent immunoassay (CLIA)
  - 5.1.2.4. Fluorescent immunoassay (FIA)
  - 5.1.2.5. Lateral flow assay (LFA)
  - 5.1.2.6. Rapid Test
  - 5.1.2.7. Others
- 5.1.3. By Product
  - 5.1.3.1. Reagents
  - 5.1.3.2. Instruments
  - 5.1.3.3. Software & Services
- 5.1.4. By Application
  - 5.1.4.1. Oncology
  - 5.1.4.2. Endocrinology
  - 5.1.4.3. Infectious diseases, Allergy & Autoimmune Diseases
  - 5.1.4.4. Environmental Pollution
  - 5.1.4.5. Food Technology
  - 5.1.4.6. Proteomics
  - 5.1.4.7. Cardiac Biomarker
  - 5.1.4.8. Drug Monitoring
  - 5.1.4.9. Others
- 5.1.5. By End-user
  - 5.1.5.1. Hospitals
  - 5.1.5.2. Clinical Laboratories
  - 5.1.5.3. Academics & Research Centers
  - 5.1.5.4. Pharma & Biotech Industry
  - 5.1.5.5. Others
- 5.1.6. United States*
  - 5.1.6.1. Market Size & Forecast
  - 5.1.6.1.1. Value
  - 5.1.6.1.2. Volume
  - 5.1.6.2. By Type
  - 5.1.6.2.1. Radioimmunoassay (RIA)
  - 5.1.6.2.2. ELISA
  - 5.1.6.2.3. Chemiluminescent immunoassay (CLIA)
  - 5.1.6.2.4. Fluorescent immunoassay (FIA)
  - 5.1.6.2.5. Lateral flow assay (LFA)
  - 5.1.6.2.6. Rapid Test
  - 5.1.6.2.7. Others
  - 5.1.6.3. By Product
  - 5.1.6.3.1. Reagents
  - 5.1.6.3.2. Instruments
  - 5.1.6.3.3. Software & Services
  - 5.1.6.4. By Application
  - 5.1.6.4.1. Oncology
  - 5.1.6.4.2. Endocrinology
  - 5.1.6.4.3. Infectious diseases, Allergy & Autoimmune Diseases
  - 5.1.6.4.4. Environmental Pollution
  - 5.1.6.4.5. Food Technology
  - 5.1.6.4.6. Proteomics
  - 5.1.6.4.7. Cardiac Biomarker
  - 5.1.6.4.8. Drug Monitoring
  - 5.1.6.4.9. Others
  - 5.1.6.5. By End-user
  - 5.1.6.5.1. Hospitals
  - 5.1.6.5.2. Clinical Laboratories
  - 5.1.6.5.3. Academics & Research Centers
  - 5.1.6.5.4. Pharma & Biotech Industry
  - 5.1.6.5.5. Others
- 5.1.7. Canada
- 5.1.8. Mexico

All segments will be provided for all regions and countries covered

5.2. Europe
- 5.2.1. Germany
- 5.2.2. France
- 5.2.3. Italy
- 5.2.4. United Kingdom
- 5.2.5. Russia
- 5.2.6. Netherlands
- 5.2.7. Spain
- 5.2.8. Turkey
- 5.2.9. Poland
5.3. South America
- 5.3.1. Brazil
- 5.3.2. Argentina
5.4. Asia-Pacific
- 5.4.1. India
- 5.4.2. China
- 5.4.3. Japan
- 5.4.4. Australia
- 5.4.5. Vietnam
- 5.4.6. South Korea
- 5.4.7. Indonesia
- 5.4.8. Philippines
5.5. Middle East & Africa
- 5.5.1. Saudi Arabia
- 5.5.2. UAE
- 5.5.3. South Africa

6. Market Mapping, 2023

6.1. By Type
6.2. By Product
6.3. By Application
6.4. By End-user
6.5. By Region

7. Macro Environment and Industry Structure

7.1. Supply Demand Analysis
7.2. Import Export Analysis
7.3. Value Chain Analysis
7.4. PESTEL Analysis
- 7.4.1. Political Factors
- 7.4.2. Economic System
- 7.4.3. Social Implications
- 7.4.4. Technological Advancements
- 7.4.5. Environmental Impacts
- 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5. Porter's Five Forces Analysis
- 7.5.1. Supplier Power
- 7.5.2. Buyer Power
- 7.5.3. Substitution Threat
- 7.5.4. Threat from New Entrant
- 7.5.5. Competitive Rivalry

8. Market Dynamics

8.1. Growth Drivers
8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

9.1. Clinical Trials
9.2. Patent Landscape
9.3. Regulatory Approvals
9.4. Innovations/Emerging Technologies

10. Key Players Landscape

10.1. Competition Matrix of Top Five Market Leaders
10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4. SWOT Analysis (For Five Market Players)
10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

13.1. Bio-Rad Laboratories, Inc.
- 13.1.1. Company Details
- 13.1.2. Key Management Personnel
- 13.1.3. Products & Services
- 13.1.4. Financials (As reported)
- 13.1.5. Key Market Focus & Geographical Presence
- 13.1.6. Recent Developments
13.2. Johnson & Johnson Services, Inc.
13.3. Immunodiagnostics Systems Holdings Plc
13.4. F. Hoffman-La Roche Ltd.
13.5. Arkray, Inc.
13.6. Siemens AG
13.7. bioMerieux SA
13.8. Danaher Corporation
13.9. Sysmex Corporation
13.10. Abbott Laboratories Inc.
13.11. Diasorin S.P.A.
13.12. Thermo Fisher Scientific, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

免疫診断の世界市場：製品タイプ別、用途別、エンドユーザー別、地域別、機会、予測、2017年～2031年

Immunodiagnostics Market Assessment, By Type, By Product, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界の免疫診断市場の見通し、2017年～2031年

第5章世界の免疫診断市場の見通し、地域別、2017年～2031年

第6章市場マッピング、2023年

第7章マクロ環境と産業構造

第8章市場力学

第9章規制の枠組みとイノベーション

第10章主要参入企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要企業の見通し

第14章戦略的提言

第15章お問合せと免責事項

List of Tables

List of Figures

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Immunodiagnostics Market Outlook, 2017-2031F

5. Global Immunodiagnostics Market Outlook, By Region, 2017-2031F

6. Market Mapping, 2023

7. Macro Environment and Industry Structure

8. Market Dynamics

9. Regulatory Framework and Innovation

10. Key Players Landscape

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

14. Strategic Recommendations

15. About Us & Disclaimer

免疫診断の世界市場：製品タイプ別、用途別、エンドユーザー別、地域別、機会、予測、2017年～2031年

Immunodiagnostics Market Assessment, By Type, By Product, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の免疫診断市場の見通し、2017年～2031年

第5章 世界の免疫診断市場の見通し、地域別、2017年～2031年

第6章 市場マッピング、2023年

第7章 マクロ環境と産業構造

第8章 市場力学

第9章 規制の枠組みとイノベーション

第10章 主要参入企業の情勢

第11章 価格分析

第12章 ケーススタディ

第13章 主要企業の見通し

第14章 戦略的提言

第15章 お問合せと免責事項

List of Tables

List of Figures

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Immunodiagnostics Market Outlook, 2017-2031F

5. Global Immunodiagnostics Market Outlook, By Region, 2017-2031F

6. Market Mapping, 2023

7. Macro Environment and Industry Structure

8. Market Dynamics

9. Regulatory Framework and Innovation

10. Key Players Landscape

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

14. Strategic Recommendations

15. About Us & Disclaimer

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界の免疫診断市場の見通し、2017年～2031年

第5章世界の免疫診断市場の見通し、地域別、2017年～2031年

第6章市場マッピング、2023年

第7章マクロ環境と産業構造

第8章市場力学

第9章規制の枠組みとイノベーション

第10章主要参入企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要企業の見通し

第14章戦略的提言

第15章お問合せと免責事項